Drug Companies Drive the Psychiatric Drugging of Children

Posted: 07/24/2012 11:24 am Huffington Post  |  Dr. Peter Breggin, reform psychiatrist with Ginger Breggin – Johnson & Johnson, the company that makes the antipsychotic drug Risperdal, has tentatively agreed to a settlement of $2.2 billion to resolve a federal investigation into the company’s marketing practices. Although details are not fully finalized, this includes “a roughly $400 million criminal fine for the illegal promotion of the antipsychotic Risperdal,” according to the Wall Street Journal. It’s been well documented that Johnson & Johnson confidentially paid psychiatrists such as Harvard’s Joseph Biederman to promote adult drugs such as the powerful antipsychotic drug Risperdal for children. The company has even ghost-written at least one of the Harvard professor’s “scientific” articles.  Read more